Visikol Joins CELLINK
May 20th, 2021 - Today Visikol joins the CELLINK family through acquisition. The acquisition provides CELLINK the opportunity to [...]
Examining gene expression with RT-qPCR
At Visikol, our services have grown from our expertise in cell culture, high-content tissue imaging, and advanced digital pathology. [...]
Immune Synapse Assay for T Cell and Tumor Interaction
The immune system can be broken down into two main parts: innate and adaptive responses. An innate immune response [...]
Using Light Sheet Imaging for Fluorescence Microscopy
Light sheet fluorescence microscopy (LSFM) is a powerful tool in the life science researcher’s toolkit. While the old histopathology [...]
Cell Painting – Molecular Imaging in Drug Discovery
Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide [...]
Cell-Subtype Selection in the Creation of a 3D Liver Fibrosis Model
Griffin Ferrara2021-03-19T14:18:00-05:00Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models [...]
Bruker and Visikol Partner to Launch Light-Sheet Imaging Services
Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi [...]
Visikol Expands Product Portfolio with New Tissue Slicers
Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and [...]
Visikol named to Pharma Tech Outlook’s Top Emerging Pharma Outsourcing Companies of 2021
Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions [...]
Using Noise Reduction Methods in ImageJ to Produce High Quality Data
work with us After completing the imaging process for your desired biological model, you may find [...]